ZNF217 and ovarian carcinoma: The resistance across a confluent OVCA420-ZNF217 monolayer was consistently lower suggesting that these cells have weaker tight junctions (Fig. 1I and S1J), which further supports ZNF217’s ability to promote ovarian cancer cell migration.